Beta Cell Mass
Beta Cell Mass - Related Videos
02:25
An Assay for Analyzing Test β-Glucan as an Immunotherapy Strategy against Brain Cancer Cells
0 Views •
2025
This video demonstrates an in vitro assay utilizing β-glucans to activate microglial cells for the production of superoxide radicals, a reactive oxygen species. In brain cancer cells, the generated reactive oxidants actively suppress tumor cell proliferation and induce cell death.
09:50
In situ Quantification of Pancreatic Beta-cell Mass in Mice
0 Views •
Cited by 6 •
2010
The following protocol outlines the process of pancreatic dissection for virtual slice imaging, and the subsequent quantification of all GFP-tagged beta-cells in the entire pancreas.
12:12
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
0 Views •
Cited by 14 •
2011
Cell-mediated lymphocytotoxicity (CML) assays can be used to test autoreactive responses and study mechanisms of cell death in vitro. However, using live-cell confocal microscopic imaging techniques with fluorescent dyes, the type and kinetics of cell death as well as the pathways utilized can be studied in greater detail.
09:31
Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
0 Views •
Cited by 16 •
2012
This protocol allows one to identify factors that modulate functional beta cell mass to find potential therapeutic targets for the treatment of diabetes. The protocol consists of a streamlined method to assess islet replication and beta cell function in isolated rat islets following manipulation of gene expression with adenoviruses.
08:43
OLIgo Mass Profiling (OLIMP) of Extracellular Polysaccharides
0 Views •
Cited by 35 •
2010
A rapid way is described to gain insights into the structure of polysaccharides in an extracellular matrix. The method takes advantage of the specificity of glycosylhydrolases and the sensitivity of mass spectrometry allowing minute amounts of materials to be analyzed. This technique is adaptable to be used directly on tissue itself.
FAQs
Changes in beta cell mass reflect the balance among beta-cell development, replication, growth, and programmed cell death. Development can add beta-cell tissue, while replication and cellular growth support expansion or maintenance. Programmed cell death reduces the tissue amount. Studying these processes helps explain why pancreatic beta-cell capacity may change during development or disease.
The amount of beta-cell tissue and its insulin-releasing performance are related but not identical. Beta cell mass indicates how much insulin-producing tissue is present, whereas function reflects how effectively those cells respond to glucose. This distinction prevents researchers from interpreting tissue quantity alone as a complete measure of glucose-regulating capacity.
Glucose responsiveness shows whether the existing beta-cell tissue can release insulin appropriately when blood glucose changes. Two biological situations with similar tissue amounts could therefore have different regulatory outcomes if cellular function differs. Combining mass-related observations with insulin-release behavior gives a more informative view of overall beta-cell capacity.
This balance indicates whether beta-cell tissue is being maintained, expanded, or lost. Greater growth or replication relative to programmed cell death supports preservation or increase, whereas cell loss can reduce available insulin-producing tissue. Examining the balance helps connect cellular events with broader changes in pancreatic islets and glucose regulation.
Researchers examine changes in beta cell mass to track how pancreatic islet tissue develops, is maintained, or declines over time. These observations can be interpreted alongside beta-cell function to assess insulin-producing capacity. Such measurements provide a framework for studying disease progression and evaluating strategies intended to preserve or restore insulin production.
In diabetes research, reduced functional beta-cell capacity is relevant because it can contribute to chronic hyperglycemia. Assessing beta cell mass helps investigators determine whether changes in the amount of insulin-producing tissue may accompany disease progression. The analysis is especially informative when paired with evidence of how effectively the remaining cells release insulin.
Beta cell mass connects cellular events during pancreatic development with the organization and behavior of pancreatic islets. Researchers can use it to investigate how beta-cell tissue emerges, grows, and is maintained within this biological setting. The same concept also supports research into approaches that aim to preserve existing tissue or restore insulin production.